138 related articles for article (PubMed ID: 36596356)
21. Re-irradiation as salvage treatment in recurrent glioblastoma: A comprehensive literature review to provide practical answers to frequently asked questions.
Scoccianti S; Francolini G; Carta GA; Greto D; Detti B; Simontacchi G; Visani L; Baki M; Poggesi L; Bonomo P; Mangoni M; Desideri I; Pallotta S; Livi L
Crit Rev Oncol Hematol; 2018 Jun; 126():80-91. PubMed ID: 29759570
[TBL] [Abstract][Full Text] [Related]
22. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903
[TBL] [Abstract][Full Text] [Related]
23. Linear accelerator-based stereotactic radiosurgery for limited, locally persistent, and recurrent nasopharyngeal carcinoma: efficacy and complications.
Chua DT; Sham JS; Kwong PW; Hung KN; Leung LH
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):177-83. PubMed ID: 12694836
[TBL] [Abstract][Full Text] [Related]
24. Reirradiation for recurrent primary central nervous system tumors: Eight-year audit from a tertiary cancer care center in South India.
Menon D; Chelakkot PG
Indian J Cancer; 2017; 54(2):409-414. PubMed ID: 29469068
[TBL] [Abstract][Full Text] [Related]
25. Timing of re-irradiation in recurrent high-grade gliomas: a single institution study.
Zemlin A; Märtens B; Wiese B; Merten R; Steinmann D
J Neurooncol; 2018 Jul; 138(3):571-579. PubMed ID: 29520609
[TBL] [Abstract][Full Text] [Related]
26. External beam radiation dose escalation for high grade glioma.
Khan L; Soliman H; Sahgal A; Perry J; Xu W; Tsao MN
Cochrane Database Syst Rev; 2020 May; 5(5):CD011475. PubMed ID: 32437039
[TBL] [Abstract][Full Text] [Related]
27. A Prospective Study of Proton Beam Reirradiation for Esophageal Cancer.
Fernandes A; Berman AT; Mick R; Both S; Lelionis K; Lukens JN; Ben-Josef E; Metz JM; Plastaras JP
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):483-487. PubMed ID: 26847847
[TBL] [Abstract][Full Text] [Related]
28. Spinal cord stimulation as adjuvant during chemotherapy and reirradiation treatment of recurrent high-grade gliomas.
Clavo B; Robaina F; Jorge IJ; Cabrera R; Ruiz-Egea E; Szolna A; Otermin E; Llontop P; Carames MA; Santana-Rodríguez N; Sminia P
Integr Cancer Ther; 2014 Nov; 13(6):513-9. PubMed ID: 25228535
[TBL] [Abstract][Full Text] [Related]
29. High-dose, conventionally fractionated thoracic reirradiation for lung tumors.
Griffioen GH; Dahele M; de Haan PF; van de Ven PM; Slotman BJ; Senan S
Lung Cancer; 2014 Mar; 83(3):356-62. PubMed ID: 24433824
[TBL] [Abstract][Full Text] [Related]
30. Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation Therapy.
Gebhardt BJ; Vargo JA; Ling D; Jones B; Mohney M; Clump DA; Ohr JP; Ferris RL; Heron DE
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):195-200. PubMed ID: 29398127
[TBL] [Abstract][Full Text] [Related]
31. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
32. Large volume reirradiation as salvage therapy for glioblastoma after progression on bevacizumab.
Magnuson W; Ian Robins H; Mohindra P; Howard S
J Neurooncol; 2014 Mar; 117(1):133-9. PubMed ID: 24469853
[TBL] [Abstract][Full Text] [Related]
33. High-dose salvage re-irradiation for recurrent/progressive adult diffuse glioma: healing or hurting?
Gupta T; Maitre M; Maitre P; Goda JS; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Epari S; Sahay A; Patil V; Jalali R
Clin Transl Oncol; 2021 Jul; 23(7):1358-1367. PubMed ID: 33528810
[TBL] [Abstract][Full Text] [Related]
34. Liver reirradiation for patients with hepatocellular carcinoma and liver metastasis.
McDuff SGR; Remillard KA; Zheng H; Raldow AC; Wo JY; Eyler CE; Drapek LC; Goyal L; Blaszkowsky LS; Clark JW; Allen JN; Parikh AR; Ryan DP; Ferrone CR; Tanabe KK; Wolfgang JA; Zhu AX; Hong TS
Pract Radiat Oncol; 2018; 8(6):414-421. PubMed ID: 29937235
[TBL] [Abstract][Full Text] [Related]
35. Semicontinuous low-dose-rate teletherapy for the treatment of recurrent glial brain tumors: final report of a phase I/II study.
Siker ML; Firat SY; Mueller W; Krouwer H; Schultz CJ
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):765-72. PubMed ID: 21236600
[TBL] [Abstract][Full Text] [Related]
36. Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature.
Freese C; Takiar V; Fouladi M; DeWire M; Breneman J; Pater L
Pract Radiat Oncol; 2017; 7(2):86-92. PubMed ID: 28274399
[TBL] [Abstract][Full Text] [Related]
37. Reirradiation for locally recurrent lung cancer previously treated with radiation therapy.
Okamoto Y; Murakami M; Yoden E; Sasaki R; Okuno Y; Nakajima T; Kuroda Y
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):390-6. PubMed ID: 11872284
[TBL] [Abstract][Full Text] [Related]
38. Subventricular zone involvement at recurrence is a strong predictive factor of outcome following high grade glioma reirradiation.
Attal J; Chaltiel L; Lubrano V; Sol JC; Lanaspeze C; Vieillevigne L; Latorzeff I; Cohen-Jonathan Moyal E
J Neurooncol; 2018 Jan; 136(2):413-419. PubMed ID: 29273890
[TBL] [Abstract][Full Text] [Related]
39. Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma.
Combs SE; Edler L; Rausch R; Welzel T; Wick W; Debus J
Acta Oncol; 2013 Jan; 52(1):147-52. PubMed ID: 22686472
[TBL] [Abstract][Full Text] [Related]
40. A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas.
Dixit KS; Sachdev S; Amidei C; Kumthekar P; Kruser TJ; Gondi V; Grimm S; Lukas RV; Nicholas MK; Chmura SJ; Fought AJ; Mehta M; Raizer JJ
J Neurooncol; 2021 Dec; 155(3):297-306. PubMed ID: 34689306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
